Idiopathic systemic capillary leak syndrome: Cutaneous involvement can be misleading

Dermatology

Volumn 209, Issue 4, 2004, Pages 291-295

  Fardet, L ^a   Kerob, D ^a   Rybojad, M ^a   Vignon Pennamen, M D ^a   Schlemmer, B ^a   Guermazi, A ^b   Morel, P ^a   Lebbe C ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Livedo; Maculopapular erythematous rash; Sclerosis; Systemic capillary leak syndrome

Indexed keywords

ADULT; AGED; ARTICLE; CAPILLARY LEAK SYNDROME; CASE REPORT; CLINICAL FEATURE; ERYTHEMA; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LIVEDO RETICULARIS; MUCINOSIS; PRIORITY JOURNAL; PURPURA; SCLEROSIS; SKIN BIOPSY; SKIN DISEASE;

AGED; BIOPSY, NEEDLE; CAPILLARY LEAK SYNDROME; COMBINED MODALITY THERAPY; CRITICAL ILLNESS; DIAGNOSIS, DIFFERENTIAL; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; SKIN DISEASES, VASCULAR;

EID: 8344237596     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080851     Document Type: Article

References (30)

1. Ishihara H, Matsui A, Muraoka M, Tanabe T, Tsubo T, Matsuki A: Detection of capillary protein leakage by indocyanine green and glucose dilutions in septic patients. Crit Care Med 2000;28:620-626.
2. Marx G, Vangerow B, Burczyk C, et al: Evaluation of noninvasive determinants for capillary leakage syndrome in septic shock patients. Intensive Care Med 2000;26:1252-1258.
3. Nurnberger W, Willers R, Burdach S, Gobel U: Risk factors for capillary leakage syndrome after bone marrow transplantation. Ann Hematol 1997;74:221-224.
4. Funke I, Prummer O, Schrezenmeier H, et al: Capillary leakage syndrome associated with elevated IL-2 serum levels after allogenic BMT. Ann Haematol 1993;68:49-52.
5. Al-Homaidhi A, Prince HM, Al-Zahrani H, Doucette D, Keating A: Granulocyte-macrophage colony-stimulating factor-associated histiocytosis and capillary-leak syndrome following autologous bone marrow transplantation: Two case reports and a review of the literature. Bone Marrow Transplant 1998;21:209-214.
6. Cotran RS, Pober JS, Gimbrone MA Jr, et al: Endothelial activation during IL-2 immunotherapy. A possible mechanism for the vascular leak syndrome. J Immunol 1988;140:1883-1888.
7. Rosenstein M, Ettinghausen SE, Rosenberg SA: Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin-2. J Immunol 1986;137:1735-1738.
8. Remick DG, Kunkel R, Larrick JW, Kunkel SL: Acute in vivo effects of human recombinant tumor necrosis factor. Lab Invest 1987;56:583-590.
9. Zhang W, Ewan PW, Lachmann PJ: The paraproteins in systemic capillary leak syndrome. Clin Exp Immunol 1993;93:424-429.
10. Piette AM, de Rohan-Chabot P, Chapman A, Gepner P, Brenot F, Loirat P: Choc hypovolémique par augmentation de la perméabilité capillaire associé à une gammapathie monoclonale. Ann Méd Interne 1985;136:572-574.
11. Clarkson B, Thompson D, Horwith M, Luckey EH: Cyclical edema and shock due to increased capillary permeability. Am J Med 1960;29:193-216.
12. Amoura Z, Papo T, Ninet J, et al: Systemic capillary leak syndrome: Report on 13 patients with special focus on course and treatment. Am J Med 1997;103:514-519.
13. Janin-Manificat L, Martelet M, Guy H, Besancenot JF, Cortet P: Choc hypovolémique par augmentation de la perméabilité capillaire: un cas sans dysglobulinémie monoclonale. Nouv Presse Méd 1982;11:2716.
14. Teelucksingh S, Padfield PL, Edwards CR: Systemic capillary leak syndrome. Q J Med 1990;75:515-524.
15. Atkinson JP, Waldmann TA, Stein SF, et al: Systemic capillary leak syndrome and monoclonal IgG gammapathy: Studies in a sixth patient and review of the literature. Medicine 1977;56:225-239.
16. Barnadas MA, Cistero A, Sitjas D, Pascual E, Puig X, de Moragas J: Systemic capillary leak syndrome. J Am Acad Dermatol 1995;32:364-366.
17. Dolberg-Stolik OC, Putterman C, Rubinow A, Rivkind AI, Sprung CL: Idiopathic capillary leak syndrome complicated by massive rhabdomyolysis. Chest 1993;104:123-126.
18. Cicardi M, Gardinali M, Bisiani G, Rosti A, Allavena P, Agostoni A: The systemic capillary leak syndrome: Appearance of interleukin-2-receptor-positive cells during attacks. Ann Intern Med 1990;113:475-477.
19. Wolkenstein P, Chosidow O, Wechsler J, et al: Cutaneous side effects associated with interleukin 2 administration for metastatic melanoma. J Am Acad Dermatol 1993;28:66-70.
20. Gaspari AA, Lotze MT, Rosenberg SA, Stern JB, Katz SI: Dermatologic changes associated with interleukin 2 administration. JAMA 1987;258:1624-1629.
21. Larbre B, Nicolas JF, Sarret Y, Tognet E, Mercatello A, Thivolet J: Immunothérapie par interleukin-2 et manifestations cutanées. Ann Dermatol Vénéréol 1993;120:528-533.
22. Eeckout I, Vogelaers D, Geerts ML, Naeyaert JM: Xanthomas due to generalized oedema. Br J Dermatol 1997;136:601-603.
23. el Wady Z, Bagot M, Wechsler J, et al: Syndrome de fuite capillaire révélant un lymphome T diffus mixte. Ann Dermatol Vénéréol 1991;118:882-883.
24. Dereure O, Portales P, Clot J, Guilhou JJ: Biclonal Sézary syndrome with capillary leak syndrome. Dermatology 1994;188:152-156.
25. Carsuzaa F, Pierre C, Morand JJ, Farnarier C, Marrot F, Kaplanski G: Syndrome de fuite capillaire révélant une papulo- érythrodermie d'Ofuji. Ann Dermatol Vénéréol 1996;123:559-562.
26. McGregor JM, Barker JN, MacDonald DM: Pulmonary capillary leak syndrome complicating generalized pustular psoriasis: Possible role of cytokines. Br J Dermatol 1991;125:472-474.
27. O'Donnell PG, Hughes JR, Higgins EM, Groves RW, Pembroke AC: A fatal case of capillary leak syndrome in erythrodermic psoriasis. Br J Dermatol 1995;132:160-161.
28. Rauzy O, Adoue D, Arlet P: Chronic systemic capillary leak syndrome not requiring treatment? Am J Med 1998;105:360.
29. Kao NL, Wendell Richmond G, Luskin AT: Systemic capillary leak syndrome. Chest 1993;104:1637-1638.
30. Stirling CM, Boulton-Jones JM, Simpson K: Progressive oedema in a 30-year-old. Lancet 1998;352:450.